Merck is undergoing a strategic restructuring, resulting in immediate job cuts in administration, sales, and research as part of a plan to save $3 billion by 2027.

MSD has said it will cut $3 billion off its annual costs by the end of 2027 as it prepares for the end of patent protection ...

General market weakness greeted the closing bell on Thursday on both sides of the border, as suspense reigned over whether a ...

Regions face reduced federal research funding and shrinking venture capital for startups, though rankings stay consistent.

Review the current Merck & Co Inc (MRK:XNYS) growth, profitability and efficiency, financial health, and cash flow key metrics to decide if MRK is the best investment for you.